The epidemiology of endometrial cancer in young women

A case-control study was conducted in Los Angeles County, California, of 127 endometrial cancer cases aged 45 years or less at diagnosis, to investigate the role of fertility, obesity and exogenous oestrogens in the development of the disease in young women. Use of sequential oral contraceptive (SOCs) or oestrogen replacement therapy (ERT) for greater than or equal to 2 years was strongly associated with increased risk of endometrial cancer. After excluding these cases, since the SOC or ERT use was probably the cause of their disease, we were left with 110 case-control pairs for further study. Among these remaining case-control pairs increasing parity was strongly associated with decreased risk (relative risk of 0.12 for women of parity 3 compared to nulliparous women, P less than 0.001). Current weight was associated with increased risk (relative risk of 17.7 for women weighing greater than or equal to 190 lbs compared to women weighing less than 130 lbs, P less than 0.001). Combination oral contraceptive (COC) use was associated with a decreased risk, which decreased with duration of COC use (relative risk of approximately 0.28 at 5 years of use, P less than 0.001), but the estimate of the protective effect was reduced and became statistically non-significant when allowance was made for weight and parity. The protective effect of COC use was only clearly evident in women who had less than 3 live-births and weighed less than 170 lbs. These results provide further support for the "unopposed" oestrogen hypothesis of the aetiology of endometrial cancer.

Abstract licence: CC BY

1. 1.

   Breslow N. E., Day N. E., Halvorsen K. T., Prentice R. L., Sabai C. Estimation of multiple relative risk functions in matched case-control studies. Am J Epidemiol. 1978;108(4):299-307.

   Not in our library10.1093/oxfordjournals.aje.a112623 (opens in a new tab)

2. 2.

   DAMON A. Host factors in cancer of the breast and uterine cervix and corpus. J Natl Cancer Inst. 1960;24:483-516.

   Not in our library

3. 3.

   DOCKERTY M. B., LOVELADY S. B., FOUST G. T. Carcinoma of the corpus uteri in young women. Am J Obstet Gynecol. 1951;61(5):966-981.

   Not in our library10.1016/0002-9378(51)90298-0 (opens in a new tab)

4. 4.

   Elwood J. M., Cole P., Rothman K. J., Kaplan S. D. Epidemiology of endometrial cancer. J Natl Cancer Inst. 1977;59(4):1055-1060.

   Not in our library10.1093/jnci/59.4.1055 (opens in a new tab)

5. 5.

   Henderson B. E., Ross R. K., Pike M. C., Casagrande J. T. Endogenous hormones as a major factor in human cancer. Cancer Res. 1982;42(8):3232-3239.

   Not in our library

6. 6.

   Holford T. R., White C., Kelsey J. L. Multivariate analysis for matched case-control studies. Am J Epidemiol. 1978;107(3):245-256.

   Not in our library10.1093/oxfordjournals.aje.a112531 (opens in a new tab)

7. 7.

   Hsueh A. J., Peck E. J., clark J. H. Progesterone antagonism of the oestrogen receptor and oestrogen-induced uterine growth. Nature. 1975;254(5498):337-339.

   Not in our library10.1038/254337a0 (opens in a new tab)

8. 8.

   Hulka B. S., Chambless L. E., Kaufman D. G., Fowler W. C., Greenberg B. G. Protection against endometrial carcinoma by combination-product oral contraceptives. JAMA. 1982;247(4):475-477.

   Not in our library

9. 9.

   Kaufman D. W., Shapiro S., Slone D., Rosenberg L., Miettinen O. S., Stolley P. D., Knapp R. C., Leavitt T., Watring W. G., Rosenshein N. B. Decreased risk of endometrial cancer among oral-contraceptive users. N Engl J Med. 1980;303(18):1045-1047.

   Not in our library10.1056/nejm198010303031807 (opens in a new tab)

10. 10.

    Kelsey J. L., LiVolsi V. A., Holford T. R., Fischer D. B., Mostow E. D., Schwartz P. E., O'Connor T., White C. A case-control study of cancer of the endometrium. Am J Epidemiol. 1982;116(2):333-342.

    Not in our library10.1093/oxfordjournals.aje.a113417 (opens in a new tab)

11. 11.

    La Vecchia C., Franceschi S., Gallus G., Decarli A., Colombo E., Mangioni C., Tognoni G. Oestrogens and obesity as risk factors for endometrial cancer in Italy. Int J Epidemiol. 1982;11(2):120-126.

    Not in our library10.1093/ije/11.2.120 (opens in a new tab)

12. 12.

    Lyon F. A. The development of adenocarcinoma of the endometrium in young women receiving long-term sequential oral contraception. Am J Obstet Gynecol. 1975;123(3):299-301.

    Not in our library10.1016/0002-9378(75)90202-1 (opens in a new tab)

13. 13.

    MEISSNER W. A., SOMMERS S. C., SHERMAN G. Endometrial hyperplasia, endometrial carcinoma, and endometriosis produced experimentally by estrogen. Cancer. 1957;10(3):500-509.

    Not in our library10.1002/1097-0142(195705/06)10:3<500::aid-cncr2820100312>3.0.co;2-v (opens in a new tab)

14. 14.

    Mack T. M. Cancer surveillance program in Los Angeles County. Natl Cancer Inst Monogr. 1977;47:99-101.

    Not in our library

15. 15.

    Mack T. M., Pike M. C., Henderson B. E., Pfeffer R. I., Gerkins V. R., Arthur M., Brown S. E. Estrogens and endometrial cancer in a retirement community. N Engl J Med. 1976;294(23):1262-1267.

    Not in our library10.1056/nejm197606032942304 (opens in a new tab)

16. 16.

    McDonald T. W., Annegers J. F., O'Fallon W. M., Dockerty M. B., Malkasian G. D., Kurland L. T. Exogenous estrogen and endometrial carcinoma: case-control and incidence study. Am J Obstet Gynecol. 1977;127(6):572-580.

    Not in our library10.1016/0002-9378(77)90351-9 (opens in a new tab)

17. 17.

    Nisker J. A., Hammond G. L., Davidson B. J., Frumar A. M., Takaki N. K., Judd H. L., Siiteri P. K. Serum sex hormone-binding globulin capacity and the percentage of free estradiol in postmenopausal women with and without endometrial carcinoma. A new biochemical basis for the association between obesity and endometrial carcinoma. Am J Obstet Gynecol. 1980;138(6):637-642.

    Not in our library10.1016/0002-9378(80)90080-0 (opens in a new tab)

18. 18.

    Peterson E. P. Endometrial carcinoma in young women. A clinical profile. Obstet Gynecol. 1968;31(5):702-707.

    Not in our library10.1097/00006250-196805000-00018 (opens in a new tab)

19. 19.

    SOMMERS S. C., HERTIG A. T., BENGLOFF H. Genesis of endometrial carcinoma; cases 19 to 35 years old. Cancer. 1949;2(6):957-illust.

    Not in our library10.1002/1097-0142(194911)2:6<957::aid-cncr2820020604>3.0.co;2-6 (opens in a new tab)

20. 20.

    Siiteri P. K. Steroid hormones and endometrial cancer. Cancer Res. 1978;38(11 Pt 2):4360-4366.

    Not in our library

21. 21.

    Silverberg S. G., Makowski E. L. Endometrial carcinoma in young women taking oral contraceptive agents. Obstet Gynecol. 1975;46(5):503-506.

    Not in our library

22. 22.

    Smith D. C., Prentice R., Thompson D. J., Herrmann W. L. Association of exogenous estrogen and endometrial carcinoma. N Engl J Med. 1975;293(23):1164-1167.

    Not in our library10.1056/nejm197512042932302 (opens in a new tab)

23. 23.

    Tseng L., Gurpide E. Induction of human endometrial estradiol dehydrogenase by progestins. Endocrinology. 1975;97(4):825-833.

    Not in our library10.1210/endo-97-4-825 (opens in a new tab)

24. 24.

    Vermeulen A., Verdonck L. Sex hormone concentrations in post-menopausal women. Clin Endocrinol (Oxf). 1978;9(1):59-66.

    Not in our library10.1111/j.1365-2265.1978.tb03572.x (opens in a new tab)

25. 25.

    Weiss N. S., Sayvetz T. A. Incidence of endometrial cancer in relation to the use of oral contraceptives. N Engl J Med. 1980;302(10):551-554.

    Not in our library10.1056/nejm198003063021004 (opens in a new tab)

26. 26.

    Wynder E. L., Escher G. C., Mantel N. An epidemiological investigation of cancer of the endometrium. Cancer. 1966;19(4):489-520.

    Not in our library10.1002/1097-0142(196604)19:4<489::aid-cncr2820190406>3.0.co;2-w (opens in a new tab)

27. 27.

    Ziel H. K., Finkle W. D. Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med. 1975;293(23):1167-1170.

    Not in our library10.1056/nejm197512042932303 (opens in a new tab)

• The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk · 1988

• The effects of moderate physical activity on menstrual cycle patterns in adolescence: Implications for breast cancer prevention · 1987

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.